Headquarters
1326 SWIMS VALLEY DR NW, ATLANTA, GA 30327-3812, US
ATLANTA, GA, US
Abli Therapeutics Inc
From the company
ABLi Therapeutics, Inc. develops innovative treatments for Parkinson's disease and other neurodegenerative disorders by targeting non-receptor Abelson Tyrosine Kinases (Abl kinases or c-Abl) with small molecule inhibitors. Its proprietary Re-engineering Approach with Metabolism Preserved (RAMP™) drug innovation engine uses clinically validated kinase inhibitor data to design novel product candidates with enhanced brain penetration, potentially higher potency and improved safety.
Capabilities
Products & services
Where they operate
Location & facilities
Direct lines
Contact
Share quantities, requirements, and timing.
Send requirementsCompany record
Profile information
- Founded
- 2025
- Website
- ablitherapeutics.com
Source: company website
Start a conversation
Send your requirements
Quantities, certifications, delivery timing, and anything else needed to quote the work.